Rojukiss International Public Co. Ltd.
3.68
THB
+0.02
(+0.55%)
ISIN
THA159010R15
Return %
Stock
S&P 500
1Y
40.46
14.20
3Y
-21.37
81.12
5Y
-68.55
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Corrado Giaquinto
- Full Time Employees
- 179
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- 100/8,100/51-54 Wongvanich B Building Bangkok BM Thailand 10310
- IPO Date
- Feb 19, 2021
- Website
- rojukissinternational.com
- Similar Companies
- Business
- Rojukiss International Public Company Limited operates primarily in the health and beauty sector, manufacturing and distributing skin care products, color cosmetics, and food supplements. The company markets these products under various brands in both domestic and international markets, including Laos, Cambodia, Indonesia, Vietnam, and Thailand. Its products include face masks, facial moisturizers, skincare treatments such as Reju PDRN essence and Phyto-Retinol, hydrogel masks, micellar water, pore bright cream with SPF 50, B12 skin barrier cream, and wrapping masks. Founded in 2007 and headquartered in Bangkok, Thailand, Rojukiss emphasizes innovation and dermatological expertise to meet evolving consumer needs. Recent major developments include the launch of the "Rojukiss Skin Lab," an innovation center established in collaboration with strategic OEM partners to reinforce the company's R&D capabilities and dermatological product development. The company has expanded its geographic footprint by appointing official distributors and operational systems in Vietnam, Laos, Cambodia, and other Southeast Asian markets, aiming to grow international revenue from 2% to 5% by the end of 2025, with a long-term target of 20% by 2030. Additionally, Rojukiss has increased its product launch pace with new offerings such as serum treatment pads, sleeping masks, and extended product lines in collagen peptide and vitamin formulations. It also concluded a strategic collaboration on direct-to-consumer (D2C) strategies with Sasin School of Management and MIT Sloan School of Management to enhance consumer engagement and market responsiveness. The company maintains strong market leadership in the face mask segment, with a market share increase to 18.2% as of 2Q25 and continued sell-out growth in semi-credit customers and e-commerce channels. Its financial performance shows solid revenue generation supported by efficiency improvements in supply chain and inventory management, despite challenges such as retailer inventory adjustments. Rojukiss continues to pursue growth through clinically backed skincare innovation, impactful marketing, and elevated packaging design while leveraging a multi-channel distribution model covering direct country management, distributor-led approaches in critical markets, and wholesale expansion globally. This comprehensive approach positions Rojukiss International as a leading player in Asia’s health and beauty sector advancing through innovation and regional expansion.